Shepherd Therapeutics

NEWS
Biopharmaceutical companies are focusing their drugs for smaller and smaller and more clearly delineated patient populations. No longer is a drug for lung cancer or even non-small cell lung cancer, but a much smaller segment.
There are many unusual things about Shepherd Therapeutics, but one of them is its origin.
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
IN THE PRESS
AWARDS
  • NextGen Class of 2018
JOBS